These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 14579298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HER-2/neu evaluation by fluorescence in situ hybridization on destained cytologic smears from primary and metastatic breast cancer.
    Nizzoli R, Guazzi A, Naldi N, Fraciosi V, Bozzetti C.
    Acta Cytol; 2005; 49(1):27-30. PubMed ID: 15717751
    [Abstract] [Full Text] [Related]

  • 5. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
    Liu HL, Gandour-Edwards R, Lara PN, de Vere White R, LaSalle JM.
    Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
    [Abstract] [Full Text] [Related]

  • 6. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F, Shen T, Prichard JW.
    Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
    Giltnane JM, Murren JR, Rimm DL, King BL.
    Histopathology; 2006 Aug; 49(2):161-9. PubMed ID: 16879393
    [Abstract] [Full Text] [Related]

  • 13. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization.
    Isola J, Tanner M, Forsyth A, Cooke TG, Watters AD, Bartlett JM.
    Clin Cancer Res; 2004 Jul 15; 10(14):4793-8. PubMed ID: 15269154
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
    Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG.
    Clin Cancer Res; 2002 Feb 15; 8(2):540-8. PubMed ID: 11839675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer.
    Tanner M, Järvinen P, Isola J.
    Cancer Res; 2001 Jul 15; 61(14):5345-8. PubMed ID: 11454672
    [Abstract] [Full Text] [Related]

  • 18. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
    Beatty BG, Bryant R, Wang W, Ashikaga T, Gibson PC, Leiman G, Weaver DL.
    Am J Clin Pathol; 2004 Aug 15; 122(2):246-55. PubMed ID: 15323142
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique.
    Nathanson DR, Nash GM, Chen B, Gerald W, Paty PB.
    J Am Coll Surg; 2003 Sep 15; 197(3):419-25. PubMed ID: 12946797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.